Pathway analysis with next-generation sequencing data

European Journal of Human Genetics

Volumn 23, Issue 4, 2015, Pages 507-515

  Zhao, Jinying ^a   Zhu, Yun ^a   Boerwinkle, Eric ^b   Xiong, Momiao ^b  

^a TULANE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ERROR; EXOME; FALSE POSITIVE RESULT; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; INFORMATION; NEXT GENERATION SEQUENCING; PATHWAY ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STATISTICS; AFRICAN AMERICAN; BIOLOGICAL MODEL; CASE CONTROL STUDY; CAUCASIAN; COMPUTER SIMULATION; DNA SEQUENCE; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC DATABASE; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; MYOCARDIAL INFARCTION; PROCEDURES; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

TRANSFORMING GROWTH FACTOR BETA;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; COMPUTER SIMULATION; DATABASES, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXOME; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MODELS, GENETIC; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84924753131     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.121     Document Type: Article

References (45)

1. McClellan J, King MC: Genetic heterogeneity in human diseases. Cell 2010; 141: 210-216.
2. Ackermann M, Strimmer K: A general modular framework for gene set enrichment analysis. BMC Bioinformatics 2009; 10: 47.
3. Wang K, Li M, Hakonarson H: Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010; 11: 843-854.
4. Yu K, Li Q, Bergen AW et al: Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009; 33: 700-709.
5. Chen L, Zhang L, Zhao Y et al: Prioritizing risk pathways: a novel association approach to searching for disease pathways fusing SNPs and pathways. Bioinformatics 2009; 25: 237-242.
6. O'Dushlaine C, Kennny E, Heron EA et al: The SNP ratio test: pathway analysis of genome-wid association datasets. Bioinformatics 2009; 25: 2762-2763.
7. Chai HS, Sicote H, Bailey KR et al: GLOSSI: a method to assess the association of genetic loci-sets with complex diseases. BMC Bioinformatics 2009; 10: 102.
8. Chasman DI: On the utility of gene set methods in genome-wide association studies of quantitative traits. Genet Epidemiol 2008; 32: 658-668.
9. De la Cruz O, Wen X, Ke B, Song M, Nicolae DL: Gene, region and pathway level analyses in wholegenome studies. Genet Epidemiol 2010; 34: 222-231.
10. Zhang K, Cui S, Chang S, Zhang L, Wang J: i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genomewide association study. Nucleic Acids Res 2010; 38(Suppl 2): W90-W95.
11. Schwender H, Ruczinski I, Ickstadt K: Testing SNPs and sets of SNPs for importance in association studies. Biostatistics 2011; 12: 18-32.
12. Nam D, Kim J, Kim SY, Kim S: GSA-SNP: a general approach for gene set analysis of polymorphisms. Nucleic Acids Res 2010; 38(Suppl 2): W749-W754.
13. Luo L, Peng G, Zhu Y et al: Genome-wide gene and pathway analysis. Eur J Hum Genet 2010; 18: 1045-1053.
14. Guo YF, Li J, Chen Y, Zhang LS, Deng HW: A new permutation strategy of pathway-based approach for genome-wide association. BMC Bioinformatics 2009; 10: 429.
15. Lee PH, O'Dushlaine C, Thomas B, Purcell SM: INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 2012; 28: 1797-1799.
16. Holmans P, Green EK, Pahwa JS et al: Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 2009; 85: 13-24.
17. Segrè AVDIAGRAM ConsortiumMAGIC investigators et al: Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet 2010; 6: e1001058.
18. Petersen A, Sitarik A, Luedtke A, Bekmetjev A, Tintle NL: Evaluating methods for combining rare variants data in pathway-based tests of genetic association. BMC Proc 2011; 5(Suppl 9): S48.
19. Yang W, Gu CC: Enrichment analysis of genetic association in genes and pathways by aggregating signals from both rare and common variants. BMC Proc 2011; 5(Suppl 9): S52.
20. Ngwa JS, Manning AK, Grimsby JL et al: Pathway analysis following association study. BMC Proc 2011; 5(Suppl 9): S18.
21. Uh H-W, Tsonaka R, Houwing-Duistermaat JJ: Does pathway analysis make it easier for common variants to tag rare ones. BMC Proc 2011; 5(Suppl 9): S90.
22. Sung YJ, Rice TK, Rao DC: Application of collapsing methods for continuous traits to the Genetic Analysis Workshop 17 exome sequence data. BMC Proc 2011; 5(Suppl 9): S121.
23. Luedtke A, Powers S, Petersen A et al: Evaluating methods for the analysis of rare variants in sequence data. BMC Proc 2011; 5(Suppl 9): S119.
24. Madsen BE, Browning SR: A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 2009; 5: e1000384.
25. Price AL, Kryukov GV, de Bakker PI et al: Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 2010; 86: 832-838.
26. Li B, Leal SM: Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 2008; 83: 311-321.
27. Wu MC, Lee S, Cai T et al: Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 2011; 89: 82-93.
28. Subramanian A, Tamayo P, Mootha VK et al: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
29. Henderson D, Plaschko P: Stochastic Differential Equations in Science and Engineering. World Scientific: New Jersey, 2006.
30. Sagan H: Introduction to the Calculus of Variations. Dover Publications, Inc.: New York, 1969.
31. Ramsay JO, Silverman BW: Functional Data Analysis. New York: Springer, 2005.
32. Li Y, Byrnes AE, Li M: To identify associations with rare variants, Just WhaIT: weighted haplotype and imputation-based tests. Am J Hum Genet 2010; 87: 728-735.
33. Fu W, O'Connor TD, Jun G et al: Analysis of 6, 515 exomes reveals the recent origin of most human protein-coding variants. Nature 2013; 493: 216-220.
34. Ogata H, Goto S, Sato K et al: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 1999; 27: 29-34.
35. Zachary I, Morgan RD: Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 2011; 97: 181-189.
36. Ropert S, Vignaux O, Mir O, Goldwasser F: VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque distuption. Invest Drugs 2011; 29: 1497-1499.
37. Koransky ML, Robbins RC, Blau HM: VEGF gene delivery for treatment of ischemic caridiovascular disease. Trends Cardiovasc Med 2002; 12: 108-114.
38. Giacca M, Zacchigna S: VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Ther 2012; 19: 622-629.
39. Hilbers FS, Boekel NB, van den Broek AJ et al: Genetic variants in TGFb-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer. Radiother Oncol 2012; 102: 115-121.
40. Oklu R, Hesketh R, Wicky S, Metcalfe J: TGF/activin signaling pathway activation in intimal hyperplasia and atherosclerosis. Diagn Interv Radiol 2011; 17: 290-296.
41. Tedgui A, Mallat Z: Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86: 515-581.
42. Hurt-Camejo E, Camejo G, Rosengren B et al: Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb 1992; 12: 569-583.
43. Fogelstrand P, Borén J: Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutr Metab Cardiovasc Dis 2012; 22: 1-7.
44. Kanzler I, Liehn EA, Koenen RR, Weber C: Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications. Curr Pharm Biotechnol 2011; 13: 37-45.
45. Sidhu Vaninder K., Gary D: Lopaschuk evolution of the metabolic approach to heart disease. Heart Metab 2010; 46: 5-10.